Protein amino groups

Protein amino groups consist of the primary amines found at the N-terminus of polypeptide chains and the epsilon-amino groups of lysine residues (UniProt). These groups are nucleophilic and participate in various physiological post-translational modifications, such as acetylation and ubiquitination, which are essential for cellular signaling and protein degradation (PubMed: 21884601). In clinical contexts, these groups are the primary sites for non-enzymatic glycation, where reducing sugars like glucose react to form Schiff bases and eventually advanced glycation end-products (AGEs), contributing to diabetic complications and aging (NIH: PMC3583887). Pharmacologically, protein amino groups are targeted non-specifically by chemical fixatives and disinfectants like glutaraldehyde and formaldehyde, which induce protein cross-linking to achieve antimicrobial effects (PubChem). Additionally, certain drugs like aminoguanidine have been developed to inhibit the formation of AGEs by reacting with dicarbonyl precursors before they can modify these proteinaceous amines (PubMed: 10601551). However, because these groups are ubiquitous throughout the human proteome, they are generally not considered specific therapeutic targets for systemic drug development due to the high risk of off-target toxicity and immunogenicity.

Other names

Primary aminesLysine epsilon-amino groupsN-terminal amino groupsProteinaceous amines

Covalent modification and cross-linking of primary amine groups on proteins.